We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Epigenetic Markers May be Used to Estimate Anal Cancer Risk

News   May 31, 2017 | Original story from Queen Mary University London

 
Epigenetic Markers May be Used to Estimate Anal Cancer Risk

Microscope image of abnormal cells within the anus. Credit: QMUL

 
 
 

RELATED ARTICLES

Protein Prevents Neuropathy From Chemotherapy

News

A team of researchers has discovered a novel protein that is capable of preventing the development of neuropathy in cancer patients who receive chemotherapy.

READ MORE

Protein Participates in Shift From “Fatty Liver” to Cancer

News

A protein has been discovered that is involved in the progression of a "fatty liver" to cancer. The protein "S100A11" could be harnessed as a means for early detection of cancer risk and could aid the development of new targeted therapies.

READ MORE

Stop or Go: How a Cell Maintains its Fine Motility Balance

News

Researchers identified a protein called tropomodulin as a key player in maintaining the balance between actin-filament machineries within a cell.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE